{{Rsnum
|rsid=3739008
|Gene=NPAS2
|Chromosome=2
|position=100996106
|Orientation=plus
|GMAF=0.2424
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NPAS2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 42.5 | 8.8
| HCB | 62.8 | 32.8 | 4.4
| JPT | 49.6 | 41.6 | 8.8
| YRI | 93.9 | 6.1 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 62.8 | 32.8 | 4.4
| CHD | 67.9 | 31.2 | 0.9
| GIH | 49.5 | 36.6 | 13.9
| LWK | 86.4 | 11.8 | 1.8
| MEX | 36.2 | 46.6 | 17.2
| MKK | 72.4 | 25.0 | 2.6
| TSI | 43.1 | 44.1 | 12.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=21140207
|Title=A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}